Systemic and mucosal immune responses in mice after rectal and vaginal immunization with HIV-DNA vaccine

Clinical Immunology

Volumn 102, Issue 1, 2002, Pages 12-18

  Hamajima, Kenji ^a   Hoshino, Yuka ^a   Xin, Ke Qin ^a   Hayashi, Futaba ^a   Tadokoro, Kazuyuki ^a   Okuda, Kenji ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; DNA VACCINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTERLEUKIN 12; PLASMID DNA;

ACTIVE IMMUNIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEASIBILITY STUDY; FECES; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOSTIMULATION; LYMPHOCYTE CLONE; MONONUCLEAR CELL; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; SERUM; SPLEEN CELL; SYNCYTIUM; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VAGINA DISCHARGE;

EID: 0036150480     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2001.5141     Document Type: Article

References (29)

1. Women, HIV and mucosal immunity
2. HTLV-III in the semen and blood of a healthy homosexual man
3. Induction of potent humoral and cell-mediated immune responses following direct injection of DNA encoding the HIV type 1 env and rev gene products
4. Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1
5. Enhancement of cell-mediated immunity against HIV-1 induced by coinoculation of plasmid-encoded HIV-1 antigen with plasmid expressing IL-12
6. Immunomodulatory effects of a plasmid expressing B7-2 on human immunodeficiency virus-1-specific cell-mediated immunity induced by a plasmid encoding the viral antigen
7. Intranasal administration of HIV-DNA vaccine formulated with a polymer, carboxylmethylcellulose, augments mucosal antibody production and cell-mediated immune (CMI) response
8. Intranasal administration of human immunodeficiency virus type-1 (HIV) DNA vaccine with interleukin-2 expression plasmid enhances cell-mediated immunity against HIV-1
9. HIV-DNA vaccination following transfer of a large number of activated T cells enhances immunoresponses against HIV-1
10. Intraperitoneal immunization of human subjects with tetanus toxoid induces specific antibody-secreting cells in the peritoneal cavity and in the circulation, but fails to elicit secretory IgA responses
11. Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein
12. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4
13. Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine
14. Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine
15. Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes
16. Single proline substitutions in predicted α-helices of murine granulocyte-macrophage colony-stimulating factor resulted in a loss in bioactivity and altered glycosylation
17. Granulocyte-macrophage colony-stimulating factor: An effective adjuvant for protein and peptide-base vaccine
18. Intranasal immunization of a DNA vaccine with IL-12 and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens
19. Neutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate
20. IIIBgp120
21. Genetic control of immune response to sperm whale myoglobin in mice
22. Biliary transport of IgA: Role of secretory component
23. Identification and some properties of rat secretory component
24. Effect of 3′-azido-2′,3′-dideoxythymidine (AZT) and neutralizing antibody on human immunodeficiency virus (HIV)-induced cytopathic effects: Implication of giant cell formation for the spread of virus in vivo
25. Functonal association of idiotype and I-J determinants on the antigen receptor of suppressor T cells
26. Delayed-type hypersensitivity to hen egg-white lysozyme. I. The surface phenotypes of suppressor T cells induced by intravenous injection of lysozyme-modified spleen cells, and their molecular interaction
27. Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice
28. Genes that induce immunity - DNA vaccines
29. Intracellular neutralization of virus by immunoglobulin A antibodies